メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tuberculosis Vaccines Market Size Growth Rate by Type (2020-2025)
1.3.2 Immunotherapeutic Vaccines
1.3.3 Booster Vaccines
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Tuberculosis Vaccines Market Share by Application (2020-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Vaccines Market Size
2.1.1 Global Tuberculosis Vaccines Revenue 2015-2025
2.1.2 Global Tuberculosis Vaccines Sales 2015-2025
2.2 Tuberculosis Vaccines Growth Rate by Regions
2.2.1 Global Tuberculosis Vaccines Sales by Regions 2015-2019
2.2.2 Global Tuberculosis Vaccines Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Tuberculosis Vaccines Sales by Manufacturers
3.1.1 Tuberculosis Vaccines Sales by Manufacturers 2015-2019
3.1.2 Tuberculosis Vaccines Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Tuberculosis Vaccines Revenue by Manufacturers (2015-2019)
3.2.2 Tuberculosis Vaccines Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Tuberculosis Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Tuberculosis Vaccines Price by Manufacturers
3.4 Key Manufacturers Tuberculosis Vaccines Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tuberculosis Vaccines Market
3.6 Key Manufacturers Tuberculosis Vaccines Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Immunotherapeutic Vaccines Sales and Revenue (2015-2019)
4.1.2 Booster Vaccines Sales and Revenue (2015-2019)
4.1.3 Others Sales and Revenue (2015-2019)
4.2 Global Tuberculosis Vaccines Sales Market Share by Type
4.3 Global Tuberculosis Vaccines Revenue Market Share by Type
4.4 Tuberculosis Vaccines Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Tuberculosis Vaccines Sales by Application
6 United States
6.1 United States Tuberculosis Vaccines Breakdown Data by Company
6.2 United States Tuberculosis Vaccines Breakdown Data by Type
6.3 United States Tuberculosis Vaccines Breakdown Data by Application
7 European Union
7.1 European Union Tuberculosis Vaccines Breakdown Data by Company
7.2 European Union Tuberculosis Vaccines Breakdown Data by Type
7.3 European Union Tuberculosis Vaccines Breakdown Data by Application
8 China
8.1 China Tuberculosis Vaccines Breakdown Data by Company
8.2 China Tuberculosis Vaccines Breakdown Data by Type
8.3 China Tuberculosis Vaccines Breakdown Data by Application
9 Rest of World
9.1 Rest of World Tuberculosis Vaccines Breakdown Data by Company
9.2 Rest of World Tuberculosis Vaccines Breakdown Data by Type
9.3 Rest of World Tuberculosis Vaccines Breakdown Data by Application
9.4 Rest of World Tuberculosis Vaccines Breakdown Data by Countries
9.4.1 Rest of World Tuberculosis Vaccines Sales by Countries
9.4.2 Rest of World Tuberculosis Vaccines Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.1.4 Tuberculosis Vaccines Product Introduction
10.1.5 Sanofi Recent Development
10.2 Merck
10.2.1 Merck Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.2.4 Tuberculosis Vaccines Product Introduction
10.2.5 Merck Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.3.4 Tuberculosis Vaccines Product Introduction
10.3.5 Serum Institute of India Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.4.4 Tuberculosis Vaccines Product Introduction
10.4.5 GlaxoSmithKline Recent Development
10.5 Japan BCG Lab
10.5.1 Japan BCG Lab Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.5.4 Tuberculosis Vaccines Product Introduction
10.5.5 Japan BCG Lab Recent Development
10.6 IDT Biologics
10.6.1 IDT Biologics Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.6.4 Tuberculosis Vaccines Product Introduction
10.6.5 IDT Biologics Recent Development
10.7 GreenSignal Bio Pharma
10.7.1 GreenSignal Bio Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.7.4 Tuberculosis Vaccines Product Introduction
10.7.5 GreenSignal Bio Pharma Recent Development
10.8 Taj Pharmaceuticals
10.8.1 Taj Pharmaceuticals Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.8.4 Tuberculosis Vaccines Product Introduction
10.8.5 Taj Pharmaceuticals Recent Development
10.9 Bavarian Nordic
10.9.1 Bavarian Nordic Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.9.4 Tuberculosis Vaccines Product Introduction
10.9.5 Bavarian Nordic Recent Development
10.10 China National Biotec Group
10.10.1 China National Biotec Group Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Tuberculosis Vaccines
10.10.4 Tuberculosis Vaccines Product Introduction
10.10.5 China National Biotec Group Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tuberculosis Vaccines Sales Channels
11.2.2 Tuberculosis Vaccines Distributors
11.3 Tuberculosis Vaccines Customers
12 Market Forecast
12.1 Global Tuberculosis Vaccines Sales and Revenue Forecast 2020-2025
12.2 Global Tuberculosis Vaccines Sales Forecast by Type
12.3 Global Tuberculosis Vaccines Sales Forecast by Application
12.4 Tuberculosis Vaccines Forecast by Regions
12.4.1 Global Tuberculosis Vaccines Sales Forecast by Regions 2020-2025
12.4.2 Global Tuberculosis Vaccines Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
